Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Targeting properdin in the treatment of atypical haemolytic uraemic syndrome: better than eculizumab?

Literature DB >> 30613637

Targeting properdin in the treatment of atypical haemolytic uraemic syndrome: better than eculizumab?

Kate Smith-Jackson¹, Kevin J Marchbank¹.

Abstract

Entities: Disease

Year: 2018 PMID： 30613637 PMCID： PMC6291531 DOI： 10.21037/atm.2018.10.35

Source DB: PubMed Journal: Ann Transl Med ISSN： 2305-5839

× No keyword cloud information.

21 in total

Review 1. Properdin deficiency and meningococcal disease--identifying those most at risk.

Authors: S M Linton; B P Morgan
Journal: Clin Exp Immunol Date: 1999-11 Impact factor: 4.330

Review 2. The alternative pathway of complement in disease: opportunities for therapeutic targeting.

Authors: V Michael Holers; Joshua M Thurman
Journal: Mol Immunol Date: 2004-06 Impact factor: 4.407

Review 3. Complement: central to innate immunity and bridging to adaptive responses.

Authors: B Paul Morgan; Kevin J Marchbank; M Paula Longhi; Claire L Harris; Awen M Gallimore
Journal: Immunol Lett Date: 2004-12-07 Impact factor: 3.685

Review 4. Current treatment of atypical hemolytic uremic syndrome.

Authors: Bernard S Kaplan; Rebecca L Ruebner; Joann M Spinale; Lawrence Copelovitch
Journal: Intractable Rare Dis Res Date: 2014-05

5. Inhibition of complement factor C5 protects against anti-myeloperoxidase antibody-mediated glomerulonephritis in mice.

Authors: D Huugen; A van Esch; H Xiao; C J Peutz-Kootstra; W A Buurman; J W Cohen Tervaert; J C Jennette; P Heeringa
Journal: Kidney Int Date: 2007-02-14 Impact factor: 10.612

6. Combination of factor H mutation and properdin deficiency causes severe C3 glomerulonephritis.

Authors: Allison M Lesher; Lin Zhou; Yuko Kimura; Sayaka Sato; Damodar Gullipalli; Andrew P Herbert; Paul N Barlow; Hannes U Eberhardt; Christina Skerka; Peter F Zipfel; Takayuki Hamano; Takashi Miwa; Kenneth S Tung; Wen-Chao Song
Journal: J Am Soc Nephrol Date: 2012-11-30 Impact factor: 10.121

7. Activator-specific requirement of properdin in the initiation and amplification of the alternative pathway complement.

Authors: Yuko Kimura; Takashi Miwa; Lin Zhou; Wen-Chao Song
Journal: Blood Date: 2007-10-04 Impact factor: 22.113

8. Loss of properdin exacerbates C3 glomerulopathy resulting from factor H deficiency.

Authors: Marieta M Ruseva; Katherine A Vernon; Allison M Lesher; Wilhelm J Schwaeble; Youssif M Ali; Marina Botto; Terence Cook; Wenchao Song; Cordula M Stover; Matthew Caleb Pickering
Journal: J Am Soc Nephrol Date: 2012-11-26 Impact factor: 14.978

9. Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains.

Authors: Matthew C Pickering; Elena Goicoechea de Jorge; Rubén Martinez-Barricarte; Sergio Recalde; Alfredo Garcia-Layana; Kirsten L Rose; Jill Moss; Mark J Walport; H Terence Cook; Santiago Rodriguez de Córdoba; Marina Botto
Journal: J Exp Med Date: 2007-05-21 Impact factor: 14.307